🇺🇸 FDA
Patent

US 9546164

Substituted benzamides and methods of use thereof

granted A61KA61K31/337A61K31/397

Quick answer

US patent 9546164 (Substituted benzamides and methods of use thereof) held by Xenon Pharmaceuticals Inc. expires Mon Jan 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Jan 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
38
CPC classes
A61K, A61K31/337, A61K31/397, A61K31/4015, A61K31/415